Education
About Us
Working with TipRanks
Follow Us
Cardinal Health (CAH)
NYSE:CAH
CAH Analyst Ratings
Moderate Buy
9 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CAH Stock 12 Month Forecast
Average Price Target
$144.85
▲(6.00% Upside)
| Highest Price Target$156.00 | Average Price Target$144.85 | Lowest Price Target$130.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Leerink Partners
Reiterated
03/17/25
Robert W. Baird
Reiterated
02/18/25
Jefferies
Upgraded
02/05/25
Wells Fargo
Reiterated
02/04/25
J.P. Morgan
Reiterated
02/03/25
Argus Research
Reiterated
02/03/25
Bank of America Securities
Reiterated
02/02/25
Morgan Stanley
Reiterated
01/31/25
Deutsche Bank
Reiterated
01/31/25
TD Cowen
Assigned
01/31/25
Evercore ISI
$140→$150
Buy
9.77%
Upside
Reiterated
01/31/25
Evercore ISI Sticks to Its Buy Rating for Cardinal Health (CAH)
Citi
$129→$130
Hold
-4.87%
Downside
Reiterated
01/30/25
Cardinal Health (CAH) PT Raised to $130 at CitiCiti analyst Daniel Grosslight raised the price target on Cardinal Health (NYSE: CAH) to $130.00 (from $129.00) while maintaining a Neutral rating.
Mizuho Securities
$139→$142
Buy
3.92%
Upside
Reiterated
01/30/25
Cardinal Health's Strong Performance and Strategic Acquisitions Justify Buy Rating
UBS
$134→$139
Buy
1.72%
Upside
Reiterated
11/04/24
Cardinal Health (CAH) PT Raised to $139 at UBSUBS analyst Kevin Caliendo raised the price target on Cardinal Health (NYSE: CAH) to $139.00 (from $134.00) while maintaining a Buy rating.
Barclays
$133
Buy
-2.67%
Downside
Reiterated
11/04/24
Analysts' Opinions Are Mixed on These Healthcare Stocks: Vir Biotechnology (NASDAQ: VIR), Cardinal Health (NYSE: CAH) and Waters (NYSE: WAT)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
Reiterated
03/17/25
Robert W. Baird
Reiterated
02/18/25
Jefferies
Upgraded
02/05/25
Wells Fargo
Reiterated
02/04/25
J.P. Morgan
Reiterated
02/03/25
Argus Research
Reiterated
02/03/25
Bank of America Securities
Reiterated
02/02/25
Morgan Stanley
Reiterated
01/31/25
Deutsche Bank
Reiterated
01/31/25
TD Cowen
Assigned
01/31/25
Evercore ISI
$140→$150
Buy
9.77%
Upside
Reiterated
01/31/25
Evercore ISI Sticks to Its Buy Rating for Cardinal Health (CAH)
Citi
$129→$130
Hold
-4.87%
Downside
Reiterated
01/30/25
Cardinal Health (CAH) PT Raised to $130 at CitiCiti analyst Daniel Grosslight raised the price target on Cardinal Health (NYSE: CAH) to $130.00 (from $129.00) while maintaining a Neutral rating.
Mizuho Securities
$139→$142
Buy
3.92%
Upside
Reiterated
01/30/25
Cardinal Health's Strong Performance and Strategic Acquisitions Justify Buy Rating
UBS
$134→$139
Buy
1.72%
Upside
Reiterated
11/04/24
Cardinal Health (CAH) PT Raised to $139 at UBSUBS analyst Kevin Caliendo raised the price target on Cardinal Health (NYSE: CAH) to $139.00 (from $134.00) while maintaining a Buy rating.
Barclays
$133
Buy
-2.67%
Downside
Reiterated
11/04/24
Analysts' Opinions Are Mixed on These Healthcare Stocks: Vir Biotechnology (NASDAQ: VIR), Cardinal Health (NYSE: CAH) and Waters (NYSE: WAT)
CAH Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
0
0
0
0
Buy
11
10
23
20
18
Hold
12
10
15
9
8
Sell
2
1
1
0
0
Strong Sell
0
0
0
0
0
total
25
21
39
29
26
Each month's total comprises the sum of three months' worth of ratings.
CAH Financial Forecast
CAH Stock Forecast FAQ
What is CAH’s average 12-month price target, according to analysts?
Based on analyst ratings, Cardinal Health’s 12-month average price target is $144.85.
What is CAH’s upside potential, based on the analysts’ average price target?
Cardinal Health has 6.00% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CAH a Buy, Sell or Hold?
Cardinal Health has a consensus rating of Moderate Buy which is based on 9 buy ratings, 4 hold ratings and 0 sell ratings.
What is Cardinal Health’s price target?
The average price target for Cardinal Health is $144.85. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $156.00 ,the lowest forecast is $130.00. The average price target represents 6.00% Increase from the current price of $136.65.
The highest analyst price target is $156.00 ,the lowest forecast is $130.00. The average price target represents 6.00% Increase from the current price of $136.65.
What do analysts say about Cardinal Health?
Cardinal Health’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of CAH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.